Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05532423Phase 1Completed
Phase 1, randomised, double-blind trial, sponsored by The Pennsylvania State University. Primary endpoints: Cognitive Functioning - Change in N-back test performance at 4 weeks, Changes in Cerebral Autoregulation at 4 weeks and 1 more. Started Dec 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05532423.